Faculty Opinions recommendation of Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.
Keyword(s):
2017 ◽
Vol 23
(19)
◽
pp. 5711-5719
◽
Keyword(s):
2019 ◽
Vol 513
(4)
◽
pp. 1083-1091
◽
Keyword(s):
2019 ◽
Vol 26
(2)
◽
pp. 364-372
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8559-8559
◽
Keyword(s):
Keyword(s):